Article
Impact of liver fibrosis on AAV-mediated gene transfer to mouse hepatocytes
10 Mar 2025
Abstract excerpt
Liver fibrosis, characterized by scar tissue accumulation due to liver injury, poses significant barriers to liver-targeted gene therapy. Current clinical trials exclude patients with fibrosis, as intact liver architecture is considered essential for efficient and safe adeno-associated viral vector (AAV)-mediated gene delivery. Here, we show that liver fibrosis reduces the efficiency of hepatocyte transduction by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
